Stock 300702 ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zhejiang Tianyu Pharmaceutical Co., Ltd.

Equities

300702

CNE1000034X1

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-02 EDT 		5-day change 1st Jan Change
19.2 CNY -0.78% Intraday chart for Zhejiang Tianyu Pharmaceutical Co., Ltd. -4.00% -11.56%
05-06 China Approves Tianyu Pharma's Heart Medication MT
04-30 Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024
China Approves Tianyu Pharma's Heart Medication
Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2023
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Zhejiang Tianyu Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Zhejiang Tianyu Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Tianyu Pharmaceutical Unit Passes US FDA's On-Site Inspection
Tianyu Pharma Unit Passes US FDA On-Site Inspection
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Zhuhai Rundu Pharma Gets Supplementary Application Approval For Hypertension Drug
Raw Drug Material of Tianyu Pharma's Unit Passes Regulatory Evaluation
Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Management Changes
Tianyu Pharmaceutical Unit Gets Approval to Market Hypertension Drug in China
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Tianyu Pharma Unit Gets Marketing Approval For Losartan Potassium Tablets
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Zhejiang Tianyu Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300702 Stock
  4. News Zhejiang Tianyu Pharmaceutical Co., Ltd.
  5. Other languages